Posts Tagged ‘downgraded-the-stock’
Shares of BioMarin Pharmaceutical Inc. fell Monday after a Brean Murray analyst downgraded the stock citing its value and a lack of detail on the biotechnology company’s midstage drug programs.
About Biolexis
Biolexis is a premiere online resource for life sciences professionals, investors and entrepreneurs. The site offers personalized information biotechnology news and other biotechnology resources. Information is further organized by industry sector, therapeutic areas, technology focus, service orientation, and location. With Biolexis, you can: access over 5,000 biotechnology news strories and biotechnology articles. Search biotech company information, biotech news, biotech articles and biotech related press releases.
Biotech
Categories
- Biotechnology News (1306)
Archives
- How to Train your Brain to keep you healthy and happy
- What makes you unique? Not genes so much as surrounding sequences, study finds
- How to Choose the Correct Workbenches For Your Organization’s Needs
- http://f-cup-products.blogspot.com/2010/03/puera-panic-sos-405mg-x-15-tablets-38.html
- A First: Microchips in living cells
- Enzyme Handbook: Volume 14: Class 2.7 – 2.8 Transferases EC 2.7.105 – EC 2.8.3.14
- Class 2 Transferases X: EC 2.7.1.113 – 2.7.5.7
- Seth Klarman’s Baupost Group Wins Big With Facet Biotech (FACT), Sells Some Shares
- The truth about health insurance profits
- Breaking down a three-tiered option play on the biotechnology concern (Schaeffers Research)
